Patents by Inventor Xinliang FU

Xinliang FU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12122784
    Abstract: The present invention provides a method for preparing an ecteinascidin compound and an intermediate thereof, and specifically provides a preparation method for a novel compound QT9, and a method of using QT9 to prepare an ecteinascidin compound. The method provided by the present invention has high reaction selectivity and high yield, the obtained compound is easy to purify, and defects in the prior art that multiple intermediates are oily substances, and the reaction selectivity is poor are solved. The method of the present invention is particularly applicable to industrial production.
    Type: Grant
    Filed: August 26, 2019
    Date of Patent: October 22, 2024
    Assignee: BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD.
    Inventors: Jiandong Yuan, Xinliang Fu, Zhanli Sun, Xiaopei Xing, Jingcheng Hui, Qilei Cong
  • Publication number: 20210355132
    Abstract: The present invention provides a method for preparing an ecteinascidin compound and an intermediate thereof, and specifically provides a preparation method for a novel compound QT9, and a method of using QT9 to prepare an ecteinascidin compound. The method provided by the present invention has high reaction selectivity and high yield, the obtained compound is easy to purify, and defects in the prior art that multiple intermediates are oily substances, and the reaction selectivity is poor are solved. The method of the present invention is particularly applicable to industrial production.
    Type: Application
    Filed: August 26, 2019
    Publication date: November 18, 2021
    Inventors: Jiandong YUAN, Xinliang FU, Zhanli SUN, Xiaopei XING, Jingcheng HUI, Qilei CONG